In parallel with directly establishing EPSC lines from diseased individuals, we will generate similar genetic lines created by genome engineering through CRISPR-type technologies (Forbester et al., Infect Immun, 2015; Forbester et al., Methods Mol Biol, 2016; Forbester et al., Proc Natl Acad Sci U S A, 2018).